| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Antibody |
| Molecule Category: | UNKNOWN |
| UNII: | 0JJ21K6L2I |
Pharmacology
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Complement C5 inhibitor |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Protein-Losing Enteropathies | 4 | D011504 | ClinicalTrials |
| Myasthenia Gravis | 3 | D009157 | ClinicalTrials |
| Hemoglobinuria | 3 | D006456 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4298086 |
| FDA SRS | 0JJ21K6L2I |
CONTENTS